Table 3 QoL score and VAS
| Control | Tamsulosin | Solifenacin | Combined therapy | P-value | |
|---|---|---|---|---|---|
| Median (Range) | Median (Range) | Median (Range) | Median (Range) | ||
| QoL | |||||
| Pre-insertion | 0 (0–0) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0.31 |
| After 2 weeks | 5a,b,c (4–6) | 3a,d (1–5) | 3b,e (1–5) | 2c,d,e (1–3) | < 0.001 |
| VAS | |||||
| Pre-insertion | 1 (0–2) | 1 (0–2) | 0 (0–1) | 1 (0–2) | 0.11 |
| After 2 weeks | 7a,b,c (4–9) | 4a,d (3–6) | 4b,e (2–5) | 3c,d,e (1–5) | 0.021 |